# Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study

> **NCT07045467** · PHASE1 · RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Renal Transplantation

## Interventions

- **DRUG:** Remimazolam Besylate

## Key facts

- **NCT ID:** NCT07045467
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07045467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07045467, "Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07045467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*